TABLE 5.

Prevalence of carbapenem resistance in Acinetobacter spp. in various parts of the world

RegionPeriodSettingResistance (%)Reference
ImipenemMeropenem
North America
    15 centers2002-2004Nonduplicate clinical isolates8.36.5 78
    24 centers2001Non-ICU isolates6.110.4 35
    15 centers2006All isolates3353 40
South America
    25 centers2002-2004Nonduplicate clinical isolates28.128.5 78
    7 countries2001Nonduplicate clinical isolates16.318.1 73
Europe
    48 centers2002-2004Nonduplicate clinical isolates30.226.9 78
    37 centers1997-2000Nonduplicate clinical isolates1614 77
Asia/Pacific, 2 centers2002-2004Nonduplicate clinical isolates1.26.0 78
Australia1999-2004Nonduplicate clinical isolates1111 78